Feasibility of Monitoring Biochemical and Haemodynamic Effects of Angiotensin Converting Enzyme Inhibitors

E-ISSN： 2055-2335|36|4|275-277

ISSN： 1445-937x

Source： JOURNAL OF PHARMACY PRACTICE AND RESEARCH, Vol.36, Iss.4, 2006-12, pp. : 275-277

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Effects of angiotensin II and angiotensin-converting enzyme inhibitors on human myocardium

By Lenz O. Schmid B. Kilter H. La Rosee K. Flesch M. Kuhn-Regnier F. Sudkamp M. Bohm M.

European Journal of Pharmacology, Vol. 294, Iss. 1, 1995-01 ,pp. : 17-27

Elsevier

Access to resources Recommend Favorite

Effects of angiotensin-converting enzyme and neutral endopeptidase inhibitors: influence of bradykinin

By Pham I. Gonzalez W. Doucet J. Fournie-Zaluski M.-C. Roques B.P. Michel J.-B.

European Journal of Pharmacology, Vol. 296, Iss. 3, 1996-02 ,pp. : 267-276

Elsevier

Access to resources Recommend Favorite

Effect of Pre-operative Angiotensin-converting Enzyme Inhibitors on Haemodynamic Parameters and Vasoconstrictor Requirements in Patients Undergoing Off-pump Coronary Artery Bypass Surgery

By Lee YK Na SW Kwak YL Nam SB

The Journal of International Medical Research, Vol. 33, Iss. 6, 2005-11 ,pp. : 693-702

Field House Publishing

Access to resources Recommend Favorite

Ongoing trials involving angiotensin-converting enzyme inhibitors

By Nadar Sunil Lip Gregory YH

Expert Opinion on Investigational Drugs, Vol. 11, Iss. 11, 2002-11 ,pp. : 1633-1643

Informa Healthcare

Access to resources Recommend Favorite

Chemistry and Pharmacology of Angiotensin-Converting Enzyme Inhibitors

Current Pharmaceutical Design, Vol. 21, Iss. 13, 2015-04 ,pp. : 1764-1775

Bentham Science Publishers

Access to resources Recommend Favorite